Probiotics: A Review on Microbiome That Helps for Better Health – A Dermatologist’s Perspective
Sane Roja Renuka1, N. Ashok Kumar1, D. Manoharan1★, Dama Kondaiah Naidu1★ Corresponding author
- 1Department of Dermatology Venereology Leprosy, Sree Balaji Medical College and Hospital, BIHER, Chrompet, Chennai, Tamil Nadu, India.
CORRESPONDENCE
D. Manoharan
Department of Dermatology Venereology Leprosy, Sree Balaji Medical College and Hospital, BIHER, Chrompet, Chennai, Tamil Nadu, India.
Received: 23-01-2023; Revised: 29-03-2023; Accepted: 30-03-2023.
Volume 14, Issue 1 · pp. 5–13 · PUBLISHED 2023 · DOI: 10.1177/0976500X231175225
View on J Pharmacol. Pharmacother. original site ↗
ABSTRACT
Commensal microorganisms heavily influence human health and disease pathogenesis, and the impact of the skin microbiome on numerous skin illnesses has recently piqued researchers’ interest, in addition to the gut microbiome. Probiotics are live microbial organisms that are good for the host’s health when given in sufficient proportions. The concept of probiotics has sparked much curiosity and scientific investigation since its inception. Probiotics alter the intestinal microbiota and are employed as a treatment technique for a variety of diseases. Despite several studies, the significance of probiotics in dermatological illnesses such as acne, vaginal infections, and atopic dermatitis has yet to be demonstrated. Evidence pointing to the “gut-skin axis” link has increased, and intestinal microbiota regulation may play a role in dermatological diseases. There is, however, no consensus on the species or the dosage to be utilized for such therapies. This article makes an effort to review recent evidence from the literature.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Renuka, S. R., Kumar, N. A., Manoharan, D., & Naidu, D. K. (2023). Probiotics: A Review on Microbiome That Helps for Better Health – A Dermatologist’s Perspective. Journal of Pharmacology and Pharmacotherapeutics, 14(1), 5–13. https://doi.org/10.1177/0976500X231175225
